Semaglutide has positive effect in chronic kidney disease
Semaglutide has a positive effect on patients with chronic kidney disease and obesity. By decreasing the amount of protein in urine, the...
top of page
Browse by category
Search
Bariatric surgery outperforms GLP-1 diabetes drugs for kidney protection
For patients with type 2 diabetes, obesity and chronic kidney disease, bariatric surgery was associated with a significant decrease in...
Journal Watch 3/07/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Journal Watch 12/06/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
FLOW trial: Semaglutide 1.0mg demonstrates 24% reduction in the risk of kidney disease-related events in T2DM and chronic kidney disease patients
Headline results from the kidney outcomes trial FLOW (Effect of Semaglutide Versus Placebo on the Progression of Renal Impairment in...
Look AHEAD study: T2DM remission associated with lower rates of heart and kidney disease
Patients that took part in the Look AHEAD study and who subsequently lost weight and experienced remission in T2DM (using diet and...
Workshop identifies challenges and opportunities to improve care for patients with obesity and CKD
A step toward improved collaboration between the nephrology and obesity medicine communities in managing persons with concurrent obesity...
Type 1 diabetics should be screened regularly for obesity and chronic kidney disease
People with type 1 diabetes should be screened regularly for obesity and chronic kidney disease, according to a study, 'Obesity and...
Browse by tag
bottom of page